Bothrops jararaca and Crotalus durissus terrificus venoms elicit distinct responses regarding to production of prostaglandins E2 and D2, and expression of cyclooxygenases

Toxicon

Volumn 49, Issue 5, 2007, Pages 615-624

  Moreira, Vanessa ^a   Zamuner, Stella Regina ^a,b   Wallace, John L ^b   Teixeira, Catarina de Fátima Pereira ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cyclooxygenases; Prostaglandins; Snake venom

Indexed keywords

BATROXOBIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; SNAKE VENOM;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; ENZYME SUBSTRATE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; BOTHROPS; CROTALID VENOMS; CROTALUS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MICE; PROSTAGLANDIN D2;

BOTHROPS JARARACA; CHINO DEL TOMATE VIRUS; CROTALUS DURISSUS TERRIFICUS; MUS;

EID: 33947302586     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2006.09.006     Document Type: Article

References (79)

1. Amorim M.F., and Mello R.F. Intermediate nephron nephrosis from snake poisoning in man; histopathologic study. Am. J. Pathol. 30 (1954) 479-499
2. Barbosa A.M., do Amaral R.O., Teixeira C.F., Hyslop S., and Cogo J.C. Pharmacological characterization of mouse hind paw oedema induced by Bothrops insularis (jararaca ilhoa) snake venom. Toxicon 42 (2003) 515-523
3. Barr R.M., Koro O., Francis D.M., Black A.K., Numata T., and Greaves M.W. The release of prostaglandin D2 from human skin in vivo and in vitro during immediate allergic reactions. Br. J. Pharmacol. 94 (1988) 773-780
4. Barraviera B. Curso sobre acidentes por animais peçonhentos: Acidentes por serpentes do gênero Crotalus. Erq. Brás Méd. 64 (1990) 14-20
5. Barraviera B., Lomonte B., Tarkowiki A., Hanson L.A., and Meira D.A. Acute phase reactions including cytokines, in patients bitten by Bothrops spp. and Crotalus durissus terrificus in Brazil. J. Venom Anim. Toxins. 1 (1995) 11-22
6. Berg D.J., Zhang J., Lauricella D.M., and Moore S.A. Il-10 is a central regulator of cyclooxygenase-2 expression and prostaglandin production. J. Immunol. 166 (2001) 2674-2680
7. Brazil V. Do emprego da peçonha em terapêutica. Biol. Méd. 1 (1934) 7-21
8. Brigatte P., Hoffmann F.A., Bernardi M.M., Giorgi R., Fernandes I., Takehara H.A., Barros S.B.M., Almeida M.G., and Cury Y. Tolerance to the antinociceptive effect of Crotalus durissus terrificus snake venom in mice is mediated by pharmacodynamic mechanisms. Toxicon 39 (2001) 1399-1440
9. Cardoso D.F., and Mota I. Effect of Crotalus venom on the humoral and cellular immune response. Toxicon 35 (1997) 607-612
10. Cardoso D.F., Lopes-Ferreira M., Faquim-Mauro E.L., Macedo M.S., and Farsky S.H. Role of crotoxin, a phospholipase A2 isolated from Crotalus durissus terrificus snake venom, on inflammatory and immune reactions. Mediators Inflamm. 10 (2001) 125-133
11. Cardoso J.L., Fan H.W., Franca F.O., Jorge M.T., Leite R.P., Nishioka S.A., Ávila A., Sano-Martins I.S., Tomy S.C., and Santoro M.L. Randomized comparative trial of three antivenoms in the treatment of envenoming by lance-headed vipers (Bothrops jararaca) in São Paulo, Brazil. Q. J. Med. 86 (1993) 315-325
12. Chaves F., Barbosa M., and Gutierrez J.M. Pharmacological study of edema induced by venom of the snake Bothrops asper (Terciopelo) in mice. Toxicon 33 (1995) 31-39
13. Chisari A., Spinedi E., Voirol M.J., Giovambattista A., and Gaillard R.C. A phospholipase A2-related snake venom (from Crotalus durissus terrificus) stimulates neuroendocrine and immune functions: determination of different sites of action. Endocrinology 139 (1998) 617-625
14. Chrousos G.P. The hypothalamic-pituitaqry-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332 (1995) 1351-1362
15. Cunha F.Q., Lorenzetti B.B., Poole S., and Ferreira S.H. Interleukin-8 as a mediator of sympathetic pain. Br. J. Pharmacol. 104 (1991) 765-767
16. Cunha F.Q., Poole S., Lorenzetti B.B., and Ferreira S.H. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br. J. Pharmacol. 107 (1992) 660-664
17. Cupo P., Azevedo-Marques M.M., and Hering S.E. Clinical and laboratory features of South American rattlesnake (Crotalus durissus terrificus) envenomation in children. Trans. R. Soc. Trop. Med. Hyg. 82 (1988) 924-929
18. Cury Y., Teixeira C.F.P., and Farsky S.H.P. Lack of effect of endogenous corticosteroids on the acute inflammatory reaction (edema) induced by Bothrops jararaca venom (BJV) in rats. Toxicon 35 (1997) 773-776
19. Davidson J., Kerr A., Guy K., and Rotondo D. Prostaglandin and fatty acid modulation of Escherichia coli O157 phagocytosis by human monocytic cells. Immunology 94 (1998) 228-234
20. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., and de Vries J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174 (1991) 1209-1220
21. Di Rosa M., Ialenti A., Ianaro A., and Sautebin L. Interaction between nitric oxide and cyclooxygenase pathways. Prostaglandins Leukot. Essent. Fatty Acids 54 (1996) 229-238
22. Fantuzzi G., Di Santo E., Sacco S., Benigni F., and Ghezzi P. Role of the hypothalamus-pituitary-adrenal axis in the regulation of TNF production in mice. Effect of stress and inhibition of endogenous glucocorticoids. J. Immunol. 155 (1995) 3552-3555
23. Farsky S.H.P., Costa-Cruz J.W.M., Cury Y., and Teixeira C.F.P. Leokocyte response induced by Bothrops jararaca crude venom. In vivo and in vitro studies. Toxicon 35 (1997) 85-93
24. Farsky S.P., Sannomiya P., and Garcia-Leme J. Secreted glucocorticoids regulate leukocyte-endothelial interactions in inflammation. A direct vital microscopic study. J. Leukoc. Biol. 57 (1995) 379-386
25. Fernández-Morata J.C., Mullol J., Fuentes M., Pujols L., Roca-Ferrer J., Perez M., Xaubet A., and Picado C. Regulation of cyclooxygenase-1 and -2 expression in human nasal mucosa. Effects of cytokines and dexamethasone. Clin. Exp. Allergy 30 9 (2000) 1275-1284
26. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., and O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147 (1991) 3815-3822
27. Flores C.A., Zappellini A., and Prado-Franceschi J. Lypoxygenase-derived mediators may be involved in in vivo neutrophil migration induced by Bothrops erytromelas and Bothrops alternatus venom. Toxicon 31 (1993) 1551-1559
28. Garcia Leme J., and Farsky S.P. Hormonal control of inflammatory responses. Mediat. Inflamm. 2 (1993) 181-198
29. Garcia Leme J., and Schapoval E.E.S. Stimulation of the hypothalamus-pituitary-adrenal axis by compounds formed in inflamed tissue. Br. J. Pharmac. 53 (1975) 75-83
30. Giles H., and Leff P. The biology and pharmacology of PGD2. Prostaglandins 35 (1988) 277-300
31. Giorgi R., Bernardi M.M., and Cury Y. Analgesic effect evoked by low molecular weight substances extracted from Crotalus durissus terrificus venom. Toxicon 31 (1993) 1257-1265
32. Harris S.G., Padilla J., Koumas L., Ray D., and Phipps R.P. Prostaglandins as modulators of immunity. Trends Immunol. 23 (2002) 144-150
33. Hart P.H. Regulation of the inflammatory response in asthma by mast cell products. Immunol. Cell Biol. 79 (2001) 149-153
34. Hartert T.V., Dworski R.T., Mellen B.G., Oates J.A., Murray J.J., and Sheller J.R. Prostaglandin E(2) decreases allergen-stimulated release of prostaglandin D(2) in airways of subjects with asthma. Am. J. Respir. Crit. Care Med. 162 (2000) 637-640
35. Hata A.N., and Breyer R.M. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol. Therap. 103 (2004) 147-166
36. Herschman H.R. Function and regulation of prostaglandin synthase 2. Adv. Exp. Med. Biol. 469 (1999) 3-8
37. Ito S., Narumiya S., and Hayaishi O. Prostaglandin D2: a biochemical perspective. Prostaglandins Leukot. Essent. Fatty Acids 37 (1989) 219-234
38. James M.J., Penglis P.S., Caughey G.E., Demasi M., and Clenland L.G. Eicosanoids production by human monocytes: does COX-2 contribute to a self-limiying inflammatory response?. Inflamm. Res. 50 (2001) 249-253
39. Kanaoka Y., and Urade Y. Hematopoietic prostaglandin D synthase. Prostaglandins Leukot. Essent. Fatty Acids 69 (2003) 163-167
40. Kennedy C.R., Zhang Y., Brandon S., Guan Y., Coffe K., Funk C.D., Magnuson M.A., Oates J.A., Breyer M.D., and Breyer R.M. Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat. Med. 5 (1999) 217-220
41. Knundsen P.J., Dinarello C.A., and Strom T.B. Prostaglandins post-transcriptionally inhibit monocyte expression of interleukin-1 activity by increasing intracellular cyclic adenosine monophosphate. J. Immunol. 137 (1986) 3189-3194
42. Kozlov V., Poveshchenko A., and Gromykhina N. Some mechanisms involved in the prostaglandin E2 immunosuppressive effect in (CBA×C57BL)F1 mice in vivo. Cell. Immunol. 128 (1990) 242-249
43. Kunkel S.L., Wiggins R.C., Chensue S.W., and Larrick J. Regulation of macrophage tumor necrosis factor production by prostaglandin E2. Biochem. Biophys. Res. Commun. 137 (1986) 404-410
44. Landucci E.C., Antunes E., Donato J.L., Faro R., Hyslop S., Marangoni S., Oliveira B., Cirino G., and de Nucci G. Inhibition of carrageenin-induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2. Br. J. Pharmacol. 114 (1995) 578-583
45. 2 in lipopolysaccharide-stimulated rat peritoneal macrophages. Biochem. Biophys. Res. Commun. 230 (1997) 110-114
46. Mizoguchi A., Eguchi N., Kimura K., Kiyohara Y., Qu W.M., Huang Z.L., Mochizuki T., Lazarus M., Kobayashi T., Kaneko T., Narumiya S., Urade Y., and Hayaishi O. Dominant localization of prostaglandin D receptors on arachinoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep. Proc. Natl. Acad. Sci. USA 98 (2001) 11674-11679
47. Molloy E.S., and McCarthy G.M. Eicosanoids, osteoarthritis, and crystal deposition diseases. Curr. Opin. Rheumatol. 17 (2005) 346-350
48. Morham S.G., Langenbach R., Loftin C.D., Tiano H.F., Vouloumanos N., Jennette J.C., Mahler J.F., Kluckman K.D., Ledford A., Lee C.A., Smithies O., and Smithies O. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83 (1995) 473-482
49. Murray J.J., Tonnel A.B., Brash A.R., Roberts II L.J., Gosset P., Workman R., Capron A., and Oates J.A. Release of prostaglandin D2 into human airways during acute antigen challenge. N. Engl. J. Med. 315 (1986) 800-804
50. Nakamura M., and Ferreira S.H. A peripheral sympathetic component in inflammatory hyperalgesia. Eur. J. Pharmacol. 135 (1987) 145-153
51. 2, cyclooxygenases, and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat perotoneal macrophages. J. Immunol. 160 (1998) 2974-2982
52. Narumiya S., and Fitzgerald G.A. Genetic and pharmacological analysis of prostanoid receptor function. Clin. Invest. 108 (2001) 25-30
53. Nataraj C., Thomas D.W., Tilley S.L., Nguyen M.T., Mannon R., Koller B.H., and Coffman T.M. Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse. J. Clin. Invest. 108 (2001) 1229-1235
54. Newton R., Kuitert L.M., Slater D.M., Adcock I.M., and Barnes P.J. Cytokine induction of cytosolic phospholipase A2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells. Life Sci. 60 (1997) 67-78
55. Niiro H., Otsuka T., Ogami E., Yamaoka K., Nagano S., Akahoshi M., Nakashima H., Arinobu Y., Izuhara K., and Niho Y. MAP kinase pathways as a route for regulatory mechanisms of IL-10 and IL-4 which inhibit COX-2 expression in human monocytes. Biochem. Biophys. Res. Commun. 250 (1998) 200-205
56. Nishijima M., Amano F., Akamatsu Y., Akagawa K., Tokunaga T., and Raetz C.R. Macrophage activation by monosaccharide precursors of Escherichia coli lipid A. Proc. Natl. Acad. Sci. USA 82 (1985) 282-286
57. Oropeza-Rendon R.L., Bauer H.C., and Fischer H. Effect of prostaglandin E1 on the level of cAMP in bone marrow macrophages. Inhibition of phagocytosis and cell shape changes. J. Immunopharmacol. 2 (1980) 133-147
58. Petricevich V.L., Teixeira C.F.P., Tambourgi D.V., and Gutiérrez J.M. Increments in cytokine and nitric oxide serum levels in mice injected with Bothrops asper and Bothrops jararaca snake venoms. Toxicon 38 (2000) 1253-1266
59. Phipps R.P., Stein S.H., and Roper R.L. A new view of prostaglandin E regulation of the immune response. Immunol. Today 12 (1991) 349-352
60. Picolo G., Giorgi R., Bernardi M.M., and Cury Y. The antinociceptive effect of Crotalus durissus terrificus snake venom is mainly due to a supraspinally integrated response. Toxicon 36 (1998) 223-227
61. Poole S., Lorenzetti B.B., Cunha J.M., Cunha F.Q., and Ferreira S.H. Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia. Br. J. Pharmacol. 126 (1999) 649-656
62. Portanova J.P., Zhang Y., Anderson G.D., Hauser S.D., Masferrer J.L., Seibert K., Gregory S.A., and Isakon P.C. Selective neutralization of prostaglandin E2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J. Exp. Med. 184 (1996) 883-891
63. Posadas I., Terencio M.C., Guillen I., Ferrandiz M.L., Coloma J., Paya M., and Alcaraz M.J. Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation. Arch. Pharmacol. 361 (2000) 98-106
64. Pradelles P., Grassi J., and Mac Louf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Analyt. Chem. 57 (1985) 1170-1173
65. Reddy S.T., Winstead M.V., Tischfield J.A., and Herschman H.R. Analysis of the secretory phospholipase A(2) that mediates prostaglandin production in mast cells. J. Biol. Chem. 272 (1997) 13591-13596
66. Rocca B., and Fitzgerald G.A. Cyclooxygenases and prostaglandins: shaping up the immune response. Int. Immunopharmacol. 2 (2002) 603-630
67. Rosenfeld G. Symptomatology, pathology and treatment of snakebites in South America. In: Bucherl W., and Buckley E. (Eds). Venomous Animals and their Venoms (1971), Academic Press, New York 345-362
68. Sampaio S.C., Alba-Loureiro T.C., Brigatte P., Landgraf R.G., dos Santos E.C., Curi R., and Cury Y. Lipoxygenase-derived eicosanoids are involved in the inhibitory effect of Crotalus durissus terrificus venom or crotoxin on rat macrophage pahgocytosis. Toxicon 47 (2006) 313-321
69. Smith W.L., and Dewitt D.L. Prostaglandin endoperoxide H synthases-1 and -2. Adv. Immunol. 62 (1996) 167-215
70. Smith W.L., Dewitt D.L., and Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69 (2000) 145-182
71. Smith W.L., and Langenbach R. Why there are two cyclooxygenase isozymes?. J. Clin. Invest. 107 (2001) 1491-1495
72. Sousa e Silva M.C.C., Gonçalves L.R.C., and Mariano M. The venom of South American rattlesnakes inhibits macrophage functions and is endowed with anti-inflammatory properties. Med. Inflam. 5 (1996) 18-23
73. Takayama K., Garcia-Cardena G., Sukhova G.K., Comander J., Gimbrone Jr. M.A., and Libby P. Prostaglandin E2 supresses chemokine production in human macrophages though the EP4 receptor. J. Biol. Chem. 277 (2002) 44147-44154
74. Teixeira C.F., Cury Y., Oga S., and Jancar S. Hyperalgesia induced by Bothrops jararaca venom in rats: role of eicosanoids and platelet activating factor (PAF). Toxicon 32 (1994) 419-426
75. Trebien H.A., and Calixto J.B. Pharmacological evaluation of rat paw oedema induced by Bothrops jararaca venom. Agents Actions 26 (1989) 292-300
76. Trebino C.E., Stock J.L., Gibbons C.P., Naiman B.M., Wachtmann T.S., Umland J.P., Pandher K., Lapointe J.M., Saha S., Roah M.L., Carter D., Thomas N.A., Durtschi B.A., McNeish J.D., Hambor J.E., Jakobsson P.J., Carty T.J., Perez J.P., and Audoly L.P. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc. Natl. Acad. Aci. 100 (2003) 9044-9049
77. Warner T.D., Giuliano F., Vojnovic I., Bukasa A., Michell J.A., and Vane J.R. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxigenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc. Natl. Acad. Sci. USA 95 (1999) 7563-7568
78. Zamuner S.R., Gutiérrez J.M., Muscará M.N., Teixeira S.A., and Teixeira C.F. Bothrops asper and Bothrops jararaca snake venoms trigger microbicidal functions of peritoneal leukocytes in vivo. Toxicon 39 (2001) 1505-1513
79. Zamuner S.R., and Teixeira C.F. Cell adhesion molecules involved in the leukocyte recruitment induced by venom of the snake Bothrops jararaca. Mediators Inflamm. 11 (2002) 351-357